The Global Metagenomics Market to Rise at 15.21% of CAGR by 2027
“According to the new market research report published by Inkwood Research, the global metagenomics market is growing at 15.21% of CAGR during the forecasting period of 2019-2027.”
“Browse 57 market Data Tables and 32 Figures spread over 155 Pages, along with an in-depth TOC on global metagenomics market forecast 2019-2027.”
Metagenomics is a study of genomes recovered from environmental samples. Metagenomics may be referred to as environmental genomics, eco-genomics or community genomics. The process involved cloning and analyzing the genomes without culturing the organism. Metagenomics is a relatively new field. Bioinformatics segment and technological advancement in DNA sequencing are fueling growth in the global market. The advancement of environmental and clinical microbiology has gained immense metagenomics grip from healthcare professionals and researchers.
Advance sequencing platform is driving the metagenomics market globally
Advance DNA sequencing means determining the order of the nucleotides that make up a DNA molecule. The sequencing articulates to the scientists the kind of genetic information that is carried in a particular DNA segment. The need for a practical platform that reduces the pre-sequencing steps, sequencing DNA molecules without pre-amplification, high reading accuracy has been increasing among researchers, which is further augmenting the growth of the metagenomics market.
To learn more about this report, request a free sample copy
The global product type market comprises of instruments, software and consumables. The consumables segment contributes to the highest market share in the product market. The high adoption of consumables in the pre-sequencing process which is one of the vital steps of metagenomic sequencing protocol is driving the consumables market growth. Sample preparation, sample processing and metagenomic sequencing is a part of pre-sequencing protocol which has usage of consumables on a higher side, thus leading high demand.
North America is supplementing growth in the global metagenomics market
North America dominates the global metagenomics market due to increased research and development funding and the presence of developed countries such as the United States and Canada that are contributing the highest in the region. The rise in the number of pharmaceuticals companies advancing their product and services portfolio is also fueling the market growth in the region. The overall increase of demand for metagenomics drugs and diagnostic technology is due to rising cases of cancer, neuro diseases and cardiovascular diseases in the region.
The key giants operating in the global metagenomics market are Agilent Technologies Inc., Enteroma SA, Illumina Inc., Oxford Nanopore Technologies Ltd., Qiagen N.V., Takara Bio Inc., Perkinelmer Inc., Integragen Inc., Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Pacific Biosciences of California Inc., Swift Biosciences Inc., Thermo Fisher Scientific Inc. These companies are mainly funding in R&D to augment their product portfolio and sustain their position in the market.
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy; with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.